The purpose of this study is to evaluate the clinical outcomes (clinical efficacy and safety) of using supplemental non-invasive computational ECG and cardiac imaging analysis tools to help guide ablation of ventricular tachycardia.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
250
Use of non-invasive computational ECG and cardiac CT models to localize arrhythmia origins
UC San Diego Health
La Jolla, California, United States
Recurrent ventricular tachycardia
Ventricular tachycardia episodes defined as implantable cardioverter defibrillator (ICD) therapies (anti-tachycardia pacing and shocks)
Time frame: 1 year
All-cause death
Time frame: 1 year
Acute hemodynamic decompensation
acute development of hypotension, cardiogenic shock, escalation of inotropes/pressors, or need for unplanned percutaneous hemodynamic support
Time frame: 24 hours post-op
Unplanned prolonged ICU upgrade
In outpatient elective cases, change in patient condiction neccessitating unplanned ICU upgrade lasting longer than 48 hours.
Time frame: 48 hours
acute cerebrovascular accident (embolic)
Time frame: 24 hours post-op
acute pericardial tamponade requiring intervention
new expanding hemorrhagic pericardial effusion causing tamponade requiring urgent pericardiocentesis
Time frame: 24 hours post-op
vascular complication requiring intervention
vascular access complication (bleeding or occlusion) requiring blood transfusion or vascular procedure (such as peripheral angioplasty)
Time frame: 24 hours post-op
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.